NCT04536129View on ClinicalTrials.gov

Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

March 4, 2020

Study Completion Date

March 4, 2020

Conditions

Ocular Surface DiseaseGlaucoma

Interventions

DRUG

Hydrocortisone (CORTIVIS ®)

Once enrolled all the patients had to instill topical low dose (1,005 mg) preservative-free hydrocortisone (CORTIVIS ®- Medivis, Catania, Italy) 2 times daily in each eye for two weeks.

Trial Locations (1)

Unknown

University of Molise, Campobasso